Biophytis Announces Ordinary and Extraordinary Shareholder Meeting

• Biophytis will hold its ordinary and extraordinary shareholders’ meeting on November 12, 2026, at Silver Innov in Ivry-sur-Seine, France.
• Shareholders will vote on capital-raising authorizations of up to EUR 38 million each, including private placements capped at 30% of capital annually.
• Proposals include capital reductions lowering nominal share value to no less than EUR 0.001, alongside a reverse split of up to 100-for-1.
• A proposed buyback would cover up to 10% of capital at a maximum EUR 0.10 per share over 18 months.
• The agenda includes adopting 2025 accounts showing a EUR 8.21 million loss, with no dividend proposed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biophytis SA published the original content used to generate this news brief on October 19, 2026, and is solely responsible for the information contained therein.